Skip to Main

Search

Results 361 to 370 of 941 for ""

Tackling resistance to HIF2 drugs with an RNA-based therapy: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-resistance-to-hif2-drugs.html

Expected to be diagnosed in 2% of men and 1% of women in the U.S., kidney cancer has traditionally been one of the most challenging cancers to treat.

UTSW Research: Female sex hormones, adrenal hyperplasia, and more: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/july-research-roundup.html

For decades, researchers have assumed that women taking oral contraceptives have stable levels of sex hormones over each monthly cycle. However, a new study in the American Journal of Physiology-Endocrinology and Metabolism led by Yasin Dhaher, Ph.D., Professor of Physical Medicine & Rehabilitation

Data scientists ID potential vulnerabilities in the COVID-19 virus: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/coronavirus-vulnerabilities.html

UT Southwestern Medical Center data scientists analyzing genetic sequences of the COVID-19 coronavirus have identified potential vulnerabilities that could help in vaccine development and further study of the infectious disease now spreading worldwide.

Simmons Cancer Center awarded nearly $19 million in CPRIT funding: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/march-cprit-funding.html

Nine scientists and physicians in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center have been awarded nearly $13 million in grants from the Cancer Prevention and Research Institute of Texas (CPRIT) to support research and prevention efforts on a wide range of cancer

Studies examine different responses to SARS-CoV-2 variants: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/jan-sars-cov-2-variants.html

– Two studies led by a researcher at UT Southwestern Medical Center show the effects of different SARS-CoV-2 variants on lung tissue, revealing what may cause some COVID-19 infections to be more severe than others.

UT Southwestern joins Dallas and nation in mourning the loss of U.S. Rep. Eddie Bernice Johnson, inspirational leader and supporter: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/jan-ebj-tribute.html

UT Southwestern Medical Center joined leaders in Dallas and across the nation in mourning the loss and honoring the legacy of U.S. Rep. Eddie Bernice Johnson, an inspirational leader who helped advance the medical center’s science, research, clinical care, and educational initiatives during her

Iron supplements provided in prenatal visits improved outcomes: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/sept-prenatal-visits.html

Giving free prenatal iron supplements to medically underserved pregnant patients rather than only recommending them significantly reduced anemia and postpartum blood transfusions.

Endometriosis can complicate hysterectomies, UTSW study shows: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/oct-endometriosis-hysterectomies.html

Patients with endometriosis are more likely to experience complications during and after hysterectomies, a study by UT Southwestern Medical Center researchers shows.

Study: Tuberculosis bacteria produce cough-triggering molecule: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/tuberculosis-bacteria.html

The bacteria that cause the deadly lung disease tuberculosis appear to facilitate their own spread by producing a molecule that triggers cough.

Study finds no danger of second COVID shot in those with allergic reactions to first dose: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/second-covid-shot.html

People who had a potentially allergic reaction to their first messenger RNA COVID-19 vaccination can safely receive their second shot, according to a study of patients conducted at several medical centers, including UT Southwestern.